Federation of American Scientists Case Studies in Dual Use Biological Research Module 5.0: Antibiotic Resistance Case Study
Topic: Discussion Subtopic: Discussion Questions


Is it reasonable to rely on individual scientists to monitor the dual-use potential of their own work?


Should there be rules regarding the use of genetic manipulation technologies like RNAi?

Given the rapid advancement and specialization of biotechnology research, is it realistic to expect the NSABB and other institutional review bodies to take on responsibility for dual-use issues?

What responsibility should researchers take for dual-use research? How about companies?


Back Next
Topic History of RNAi Genetic Control in Mice Implications Discussion References Home